Tetralogic Pharmaceuticals Corp
3 additional investors
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 2 investorsnamed
2 investors on record.
The investors already on the cap table shape who leads the next round.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 3
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 2
Financing history
- Nov 29, 2012Form D equity offering · $5.0M (form d sold)Hatteras Venture Partners via Douglas ReedClarus Ventures, LLC via Michael SteinmetzFact Form D · “Tetralogic Pharmaceuticals Corp Form D, first filed 2012-12-13”
- May 20, 2011Form D equity offering · $6.0M (form d sold)Hatteras Venture Partners via Douglas ReedClarus Ventures, LLC via Michael SteinmetzFact Form D · “Tetralogic Pharmaceuticals Corp Form D, first filed 2011-05-31”
- Jul 26, 2010Form D equity offering · $12.5M (form d sold)Hatteras Venture Partners via Douglas ReedClarus Ventures, LLC via Michael SteinmetzFact Form D · “Tetralogic Pharmaceuticals Corp Form D, first filed 2010-08-10”
Investors on record
- Clarus Ventures, LLC form d related, Michael Steinmetz (strongly supported) Inference sec.gov
- Hatteras Venture Partners form d related, Douglas Reed (strongly supported) Inference sec.gov
- Clarus Ventures, LLC form d related, Michael Steinmetz (strongly supported) Inference sec.gov
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.No firm portfolio page lists this company, so no outcome is stated.